Serum response factor (SRF) is a MADS-box transcription factor that regulates musclespecific and growth factor-inducible genes by binding the consensus sequence CC(A/T) 6 GG, known as a CArG box. Because SRF expression is not restricted solely to muscle, its expression alone cannot account for the muscle-specificity of some of its target genes. To further understand the role of SRF in muscle-specific transcription, we created transgenic mice harboring lacZ transgenes linked to tandem copies of different CArG boxes with flanking sequences. CArG boxes from the SM22 and skeletal -actin promoters directed highly restricted expression in developing smooth, cardiac, and skeletal muscle cells during early embryogenesis. In contrast, the CArG box and flanking sequences from the c-fos promoter directed expression throughout the embryo, with no preference for muscle cells. Systematic swapping of the core and flanking sequences of the SM22 and c-fos CArG boxes revealed that cell type-specificity was dictated in large part by sequences immediately flanking the CArG box core. Sequences that directed widespread embryonic expression bound SRF more strongly than those that directed musclerestricted expression. We conclude that sequence variations among CArG boxes influence cell type-specificity of expression and account, at least in part, for the ability of SRF to distinguish between growth factor-inducible and muscle-specific genes in vivo.
Introduction
The MADS-box transcription factor, serum response factor (SRF), was first identified on the basis of its ability to confer serum-inducibility to the c-fos gene through a sequence known as the serum response element (SRE) (reviewed in 1). Paradoxically, SRF also regulates musclespecific genes, which are expressed specifically in post-mitotic muscle cells, thus representing a gene regulatory program incompatible with expression of growth-regulated genes. Several mechanisms have been shown to regulate SRF activity, including association with positive and negative cofactors (reviewed in 2), phosphorylation-dependent changes in DNA binding (3), alternative RNA splicing (4, 5) , and regulated nuclear translocation (6) . However, the exact mechanisms that enable SRF to distinguish between growth factor-inducible and muscle-specific genes have not been fully explained.
SRF binds as a homodimer to the DNA consensus sequence CC(A/T) 6 GG, referred to as a CArG box (7, 8) . CArG boxes are essential for expression of numerous cardiac, skeletal and smooth muscle-specific genes (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) . During embryogenesis, SRF is highly expressed in muscle cell lineages (25) (26) (27) , but it is not muscle-specific. Thus, SRF expression alone cannot account for the muscle specificity of certain of its target genes. The possibility that cell-specificity might be encoded in the sequence of the CArG box itself has been suggested by transfection assays in which CArG boxes from muscle-specific genes were shown to be preferentially active in muscle cells, whereas the c-fos SRE was active in a wider range of cell types (28) . However, other studies have concluded that CArG boxes from muscle-specific and serum-inducible genes were functionally interchangeable (29, 30) .
We and others have examined the role of SRF in the regulation of the SM22 gene. SM22, which encodes a structural protein related to troponin, is expressed specifically in developing smooth, skeletal, and cardiac muscle during embryogenesis, before becoming restricted to smooth muscle postnatally (31) (32) (33) . Transcription of SM22 is controlled by a proximal promoter region by guest on January 8, 2018 http://www.jbc.org/ Downloaded from that contains two CArG boxes; the more 3' CArG box (referred to as CArG-near) is essential for promoter activity in transgenic mice (17, 18, 34) .
To further understand the mechanism whereby SRF regulates muscle-specific transcription, we investigated whether CArG boxes from the SM22 and skeletal α-actin promoters and their immediate flanking sequences were sufficient to direct muscle-specific expression of a lacZ reporter gene in transgenic mouse embryos. We show that these transgenes are expressed specifically in smooth, cardiac, and skeletal muscle during early embryogenesis, in a pattern similar to that of the endogenous SM22 and skeletal α-actin genes. In contrast, a lacZ transgene linked to tandem copies of the c-fos SRE showed widespread embryonic expression.
Through creation of chimeric CArG boxes containing different combinations of the SM22 and cfos core and flanking sequences, we found that sequences immediately surrounding the CArG box specify the expression pattern and that CArG boxes with muscle-specificity bind SRF with reduced affinity compared to those that direct ubiquitous expression. These results are consistent with a model in which sequence variations among CArG boxes account for differences in gene expression patterns.
Materials and Methods

Construction of CArG box multimer constructs
Oligonucleotides containing the appropriate CArG box core (10 bp) and flanking sequences (15 bp each side) with HindIII sites on both ends were phosphorylated, phenol extracted, and annealed. Correct multimers were subcloned into the hsp68lacZ vector (35) 
Generation of transgenic mice
DNA was gel purified and eluted using a Nucleospin DNA purification kit (Clontech). Transgenic mice were created by pronuclear injection of DNA into fertilized oocytes and LacZ expression was assayed in FO embryos as described (36) .
β−galactosidase staining and histology
Embryos were fixed in 2% formaldehyde/0.2% glutaraldehyde in PBS on ice for 1 hour, washed twice with PBS and stained overnight at room temperature in 5 mM ferricyanide/5 mM ferrocyanide/2 mM MgCl 2 ,1 mg/ml X-Gal in dimethylformamide in PBS. Embryos were postfixed overnight in 4% formaldehyde after 2 washes in PBS. Embryos were then successively dehydrated (30%, 50%, 70%, 90%, and 100% (v/v) methanol solutions) for 1 hour each, and left in 100% methanol overnight. Embryos were cleared for 2 hours in 2:1 benzyl benzoate/benzyl alcohol, embedded in paraffin, sectioned at 5 P UHK\GUDWHG DQG VWDLQHG ZLWK 1XFOHDU )DVW 5HG (37) .
Gel mobility shift assays
SRF was translated in vitro with a TNT T7-coupled reticulocyte lysate system (Promega).
The same SM22, c-fos, and skeletal -actin CArG box oligonucleotides used for the construction of the CArG box-dependent transgenes were used as probes in gel mobility shift assays. 4 cpm of labeled probe was incubated for 20 minutes at room temperature with in vitro translated SRF and poly (dI-dC) in gel shift buffer, as described (40) . Antibody supershift experiments were performed with rabbit anti-SRF antiserum (Santa Cruz, sc-335X).
DNA-protein complexes were separated by gel electrophoresis on a 5% nondenaturing polyacrylamide gel in 0.5X TBE. Unlabeled competitor DNA was added at 25-, 50-and 100-fold
Results
Muscle-specificity of multimerized SM22 CArG elements in transgenic mouse embryos. The 1343-bp SM22 promoter is sufficient to direct expression of a lacZ reporter in developing smooth, cardiac, and skeletal muscle cells during mouse embryogenesis (Fig. 1A, 34 ).
Previous studies showed that a CArG box in the proximal SM22 promoter, referred to as CArGnear, is essential for muscle-specific expression of SM22 (17) . To determine whether this CArG box might be sufficient to confer muscle-specificity, we created a transgene (4xSM22-lacZ)
containing four tandem copies of CArG-near with 15 nucleotides of flanking sequence on each side. The CArG boxes were linked in a head-to-tail orientation upstream of a lacZ reporter under control of the heat shock protein (hsp)-68 basal promoter, which is transcriptionally silent in mouse embryos (35) .
The multimerized SM22 CArG-near element directed lacZ expression in a highly restricted pattern in F0 transgenic mouse embryos at E11.5 ( ( Fig. 2A) .
In contrast to the highly specific expression patterns of the SM22 and skeletal -actin
CArG boxes, the c-fos CArG box directed widespread embryonic expression (Fig. 2B ). This transgene was expressed in the heart, somites, and aorta, but there was also extensive staining throughout the embryo, suggesting that the c-fos CArG element was active in a wider range of cell types than the SM22 and skeletal -actin CArG boxes. The broad expression pattern of the 4xfos-lacZ transgene suggests that the c-fos CArG box is active in cells that express SRF at relatively low levels.
Transverse sections of transgenic embryos harboring the multimerized SM22 CArG and c-fos CArG box transgenes confirmed the differences in their expression patterns. LacZ was expressed specifically in the heart, somites, dorsal aorta, and ventral neural tube in embryos harboring the 4xSM22-lacZ transgene, whereas lacZ expression was observed throughout the entire embryo with the 4xfos-lacZ transgene (Fig. 3) .
Analysis of chimeric CArG elements in transgenic embryos demonstrates specificity
of expression based on flanking sequences. We next sought to identify the DNA sequences responsible for the distinctly different patterns of transgene expression directed by the SM22 and c-fos CArG boxes. We therefore created chimeric CArG elements by systematically swapping the core sequences and surrounding nucleotides of the two CArG boxes. Tandem copies of these chimeric CArG elements were linked to the hsp68-lacZ reporter and tested in F0 transgenic embryos at E11.5. As with the multimerized SM22, c-fos, and skeletal -actin CArG constructs, all of the CArG elements were organized in a head-to-tail orientation. Each CArG box was named according to the identity of the 5'-flanking, core (CC(A/T) 6 GG), and 3'-flanking nucleotides, with S referring to SM22 and F referring to c-fos (Fig. 4) . The number of CArG boxes contained in each transgene is shown in Table 1 . At least three independent transgenic embryos were examined with each construct. As shown for the parental constructs in Fig. 1 , the overall expression pattern was similar in different embryos harboring a given construct, but the intensity of expression varied, presumably because of differences in transgene copy number or sites of integration. We also examined the expression of multiple different transgenes containing between 3 and 6 tandem copies of the different CArG boxes, but saw no significant differences in (Fig. 5C-F) .
Together, these data suggest that the differences in expression pattern of different CArG element 
Discussion
SRF is an important regulator of both growth factor-inducible and muscle-specific genes, but the mechanisms whereby SRF distinguishes between these two sets of genes, which show entirely different expression patterns, are not fully resolved. Our results demonstrate that different CArG boxes with flanking sequences can direct distinct temporospatial expression patterns during mouse embryogenesis. Whereas CArG boxes from the SM22 and skeletal α-actin promoters can direct muscle-restricted transcription, the c-fos SRE directs widespread embryonic expression.
The different activities of these CArG boxes correlate with their relative affinities for SRF; CArG boxes that direct muscle-restricted expression bind SRF relatively weakly compared to those, such as the c-fos SRE, that direct widespread expression.
Differential cellular responsiveness of CArG boxes. How might different CArG
boxes encode differential information for cell type-specificity? One mechanism consistent with our results is that CArG boxes with relatively high affinity for SRF are able to detect low levels of SRF in a wide range of cell types, whereas muscle-specific CArG boxes, which exhibit reduced affinity for SRF, are only able to detect the higher levels of SRF that exist in muscle cells (as well as in certain neural cell types). According to this model, the transgenes with multimerized CArG boxes respond to endogenous SRF levels with different sensitivities, resulting in different cellular expression patterns. Consistent with this interpretation, SRF expression is highly enriched in developing muscle cell lineages and in a subset of neuroectodermal derivatives during embryogenesis (25) (26) (27) , resembling the expression patterns of the SM22 and skeletal -actin CArG-containing transgenes.
The possibility that the multimerized CArG boxes contained in our transgenes "read" SRF levels in vivo is also suggested by the similarity in expression pattern seen with the SM22
and skeletal α-actin CArG multimers. During embryogenesis, the endogenous SM22 and skeletal α-actin genes show different temporospatial expression patterns in developing muscle cell lineages (32, 33, 41, 42) . The fact that the multimerized SM22 and skeletal α-actin CArG boxes direct the same expression patterns in skeletal, cardiac and smooth muscle cells in vivo also
indicates that SRF is not solely responsible for the normal expression patterns of those genes. This is, to our knowledge, the first analysis of the potential interchangeability of CArG boxes in transgenic mice. However, previous studies of other CArG boxes in transfection assays have suggested a correlation between low-affinity DNA binding of SRF and muscle-restricted activity. Replacement of the most proximal CArG box in the skeletal-actin promoter with the cfos SRE resulted in constitutive expression of the promoter in transfected nonmuscle cells (28) .
Similarly, replacement of two CArG boxes from the smooth muscle α-actin promoter with the cfos SRE caused a relaxation in cell-specific expression in transfected cells (43) . it is unlikely that TCF plays a positive role in muscle-specific expression from these sequences.
Several myogenic cofactors for SRF have also been described. For example, the cardiac homeodomain protein Nkx2.5 and the zinc-finger transcription factor GATA4 interact with SRF to activate certain cardiac-specific genes (46, 47) and myogenic bHLH proteins have been reported to interact with SRF to regulate skeletal muscle genes (48) . Because these cofactors can associate with SRF without binding to DNA, they would not be expected to distinguish between different CArG box sequences. However, it is conceivable that binding of SRF to specific CArG boxes might influence its interactions with such factors.
The homeodomain protein phox/MHox also interacts with SRF to increase its affinity for certain CArG boxes (49, 50) and has been proposed to confer smooth muscle-specificity to a
CArG box from the smooth muscle -actin gene (51) . This type of interaction may contribute to the specificity of CArG box-dependent expression in certain cell types, but because phox is expressed predominantly in mesenchymal cells within the branchial arches and limb buds (52), it cannot account for the muscle-restricted expression of the multimerized SM22 and skeletalactin CArG sequences observed in our studies.
Simplified regulation of CArG multimers. Our approach in the present study was to investigate the activity of isolated CArG boxes and adjacent sequences outside the context of their native promoters. This is, of course, an over-simplification of the actual regulatory events that govern the activity of these sequences in vivo and does not discount the potential importance of other regulatory factors that bind sites surrounding the CArG boxes in their native promoters.
There is also evidence for complex interactions among distant CArG boxes associated with the smooth muscle -actin gene that result in selective activation of transcription in specific muscle cell types (23, J. Spencer and E. N. Olson, in preparation). The artificial transgenes analyzed in the present study would be independent of this type of regulation, which may involve long-range alterations in chromatin structure. In this regard, it is interesting to note that SRF interacts with the high mobility group protein, SSRP1, implicated in chromatin remodeling (53) .
While the SM22 and skeletal α-actin CArG multimers direct a highly restricted expression pattern at E11.5 and earlier in embryogenesis, these sequences direct more widespread expression during late fetal development and postnatally (data not shown). Thus, the mechanisms that regulate the activity of these sequences appear to change during development. This may explain why previous studies concluded that the cardiac -actin CArG and c-fos SRE were functionally interchangeable in injected Xenopus embryos (29) .
Previously, we generated transgenic mice harboring multimerized binding sites for the MADS-box transcription factor MEF2, which shares homology with the DNA binding and dimerization domains of SRF (54) . During embryogenesis, these "MEF2 sensor" mice showed highly specific expression of lacZ in developing muscle and neural cell lineages (54); the same cell types in which MEF2 is expressed at highest levels. After birth, the MEF2-lacZ transgene was downregulated in skeletal and cardiac muscle, despite high levels of MEF2 protein in these tissues, but it could be activated in response to various calcium-dependent signal transduction pathways (55, 56) . Multimerized MEF2 binding sites from the desmin enhancer, which is musclespecific, or the c-jun promoter, which is growth factor-inducible, direct similar expression patterns in vivo (54) . Together, these findings suggest that SRF and MEF2 use different mechanisms to confer cell type-specificity through their target sequences.
In summary, the results of the present study demonstrate that SRF can discriminate between different target genes based on differential affinity for CArG boxes. Such differential binding is likely to contribute to the specificity of expression of SRF-dependent genes in vivo and is likely to be profoundly influenced by cofactor interactions and intracellular signals. Embryos harboring the indicated chimeric CArG boxes upstream of hsp68-lacZ were stained for lacZ expression at E11.5. Forty two total transgenic embryos were analyzed. The number of copies of each CArG box in each transgene construct and the number of transgenic embryos examined are indicated. Table 1 , along with the number of transgenic embryos analyzed da, dorsal aorta; h, heart; m, myotome; nt, neural tube; v, umbilical vessel. 
